全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
Nutrients  2013 

Cobalamin Deficiency: Clinical Picture and Radiological Findings

DOI: 10.3390/nu5114521

Keywords: vitamin B12, cobalamin, neuropathy, subacute combined degeneration, neuroimaging

Full-Text   Cite this paper   Add to My Lib

Abstract:

Vitamin B12 deficiency causes a wide range of hematological, gastrointestinal, psychiatric and neurological disorders. Hematological presentation of cobalamin deficiency ranges from the incidental increase of mean corpuscular volume and neutrophil hypersegmentation to symptoms due to severe anemia, such as angor, dyspnea on exertion, fatigue or symptoms related to congestive heart failure, such as ankle edema, orthopnea and nocturia. Neuropsychiatric symptoms may precede hematologic signs and are represented by myelopathy, neuropathy, dementia and, less often, optic nerve atrophy. The spinal cord manifestation, subacute combined degeneration (SCD), is characterized by symmetric dysesthesia, disturbance of position sense and spastic paraparesis or tetraparesis. The most consistent MRI finding is a symmetrical abnormally increased T2 signal intensity confined to posterior or posterior and lateral columns in the cervical and thoracic spinal cord. Isolated peripheral neuropathy is less frequent, but likely overlooked. Vitamin B12 deficiency has been correlated negatively with cognitive functioning in healthy elderly subjects. Symptoms include slow mentation, memory impairment, attention deficits and dementia. Optic neuropathy occurs occasionally in adult patient. It is characterized by symmetric, painless and progressive visual loss. Parenteral replacement therapy should be started soon after the vitamin deficiency has been established.

References

[1]  Antony, A.C. Megaloblastic Anemias. In Hematology: Basic Principles and Practice, 5th ed.; Hoffman, R., Benz, E.J., Jr., Shattil, S.J., Eds.; Elsevier Churchill Livingstone: Philadelphia, PA, USA, 2009; Volume 3, p. 491.
[2]  Watanabe, F. Vitamin B12 sources and bioavailability. Exp. Biol. Med. 2007, 232, 1266–1274, doi:10.3181/0703-MR-67.
[3]  Antony, A.C. Vegetarianism and vitamin B-12 (cobalamin) deficiency. Am. J. Clin. Nutr. 2003, 78, 3–6.
[4]  Herbert, V.; Jacob, E.; Wong, K.T.; Scott, J.; Pfeffer, R.D. Low serum vitamin B12 levels in patients receiving ascorbic acid in megadoses: Studies concerning the effect of ascorbate on radioisotope vitamin B12 assay. Am. J. Clin. Nutr. 1978, 31, 253–258.
[5]  Koop, H.; Bachem, M.G. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J. Clin. Gastroenterol. 1992, 14, 288–292, doi:10.1097/00004836-199206000-00005.
[6]  Kristiansen, M.; Aminoff, M.; Jacobsen, C.; de la Chapelle, A.; Krahe, R.; Verroust, P.J.; Moestrup, S.K. Cubilin p1297l mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. Blood 2000, 96, 405–409.
[7]  Nielsen, M.J.; Rasmussen, M.R.; Andersen, C.B.; Nexo, E.; Moestrup, S.K. Vitamin B12 transportfrom food to the body’s cells—A sophisticated, multistep pathway. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 345–354, doi:10.1038/nrgastro.2012.76.
[8]  Herrmann, W.; Schorr, H.; Obeid, R.; Geisel, J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am. J. Clin. Nutr. 2003, 78, 131–136.
[9]  Honzik, T.; Adamovicova, M.; Smolka, V.; Magner, M.; Hruba, E.; Zeman, J. Clinical presentation and metabolic consequences in 40 breastfed infants with nutritional vitamin B12 deficiency—What have we learned? Eur. J. Paediatr. Neurol. 2010, 14, 488–495.
[10]  Dror, D.K.; Allen, L.H. Effect of vitamin B12 deficiency on neurodevelopment in infants: Current knowledge and possible mechanisms. Nutr. Rev. 2008, 66, 250–255, doi:10.1111/j.1753-4887.2008.00031.x.
[11]  Pennypacker, L.C.; Allen, R.H.; Kelly, J.P.; Matthews, L.M.; Grigsby, J.; Kaye, K.; Lindenbaum, J.; Stabler, S.P. High prevalence of cobalamin deficiency in elderly outpatients. J. Am. Geriatr. Soc. 1992, 40, 1197–1204.
[12]  Carmel, R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008, 112, 2214–2221, doi:10.1182/blood-2008-03-040253.
[13]  Lewerin, C.; Jacobsson, S.; Lindstedt, G.; Nilsson-Ehle, H. Serum biomarkers for atrophic gastritis and antibodies against helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy. Scand. J. Gastroenterol. 2008, 43, 1050–1056, doi:10.1080/00365520802078341.
[14]  Stabler, S.P. Clinical practice. Vitamin B12 deficiency. N. Engl. J. Med. 2013, 368, 149–160, doi:10.1056/NEJMcp1113996.
[15]  Saperstein, D.S.; Wolfe, G.I.; Gronseth, G.S.; Nations, S.P.; Herbelin, L.L.; Bryan, W.W.; Barohn, R.J. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch. Neurol. 2003, 60, 1296–1301, doi:10.1001/archneur.60.9.1296.
[16]  Langan, R.C.; Zawistoski, K.J. Update on vitamin B12 deficiency. Am. Fam. Physician 2011, 83, 1425–1430.
[17]  Lindenbaum, J.; Rosenberg, I.H.; Wilson, P.W.; Stabler, S.P.; Allen, R.H. Prevalence of cobalamin deficiency in the framingham elderly population. Am. J. Clin. Nutr. 1994, 60, 2–11.
[18]  Carmel, R.; Green, R.; Rosenblatt, D.S.; Watkins, D. Update on cobalamin, folate, and homocysteine. Hematol. Am. Soc. Hematol. Educ. Program 2003, 2003, 62–81, doi:10.1182/asheducation-2003.1.62.
[19]  Scalabrino, G. The multi-faceted basis of vitamin B-12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency. Prog. Neurobiol. 2009, 88, 203–220, doi:10.1016/j.pneurobio.2009.04.004.
[20]  Senol, M.G.; Sonmez, G.; Ozdag, F.; Saracoglu, M. Reversible myelopathy with vitamin B12 deficiency. Singap. Med. J. 2008, 49, E330–E332.
[21]  Hemmer, B.; Glocker, F.X.; Schumacher, M.; Deuschl, G.; Lucking, C.H. Subacute combined degeneration: Clinical, electrophysiological, and magnetic resonance imaging findings. J. Neurol. Neurosurg. Psychiatry 1998, 65, 822–827, doi:10.1136/jnnp.65.6.822.
[22]  Kumar, N. Nutritional neuropathies. Neurol. Clin. 2007, 25, 209–255, doi:10.1016/j.ncl.2006.11.001.
[23]  Healton, E.B.; Savage, D.G.; Brust, J.C.M.; Garrett, T.J.; Lindenbaum, J. Neurologic aspects of cobalamin deficiency. Medicine 1991, 70, 229–245.
[24]  Puri, V.; Chaudhry, N.; Goel, S.; Gulati, P.; Nehru, R.; Chowdhury, D. Vitamin B12 deficiency: A clinical and electrophysiological profile. Electromyogr. Clin. Neurophysiol. 2005, 45, 273–284.
[25]  Huang, C.R.; Chang, W.N.; Tsai, N.W.; Lu, C.H. Serial nerve conduction studies in vitamin B12 deficiency-associated polyneuropathy. Neurol. Sci. 2011, 32, 183–186.
[26]  Dommisse, J. Subtle vitamin-B12 deficiency and psychiatry: A largely unnoticed but devastating relationship? Med. Hypotheses 1991, 34, 131–140, doi:10.1016/0306-9877(91)90181-W.
[27]  Hutto, B.R. Folate and cobalamin in psychiatric illness. Compr. Psychiatry 1997, 38, 305–314, doi:10.1016/S0010-440X(97)90925-1.
[28]  Obeid, R.; McCaddon, A.; Herrmann, W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin. Chem. Lab. Med. 2007, 45, 1590–1606.
[29]  Bjelland, I.; Tell, G.S.; Vollset, S.E.; Refsum, H.; Ueland, P.M. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: The hordaland homocysteine study. Arch. Gen. Psychiatry 2003, 60, 618–626, doi:10.1001/archpsyc.60.6.618.
[30]  Bottiglieri, T.; Laundy, M.; Crellin, R.; Toone, B.K.; Carney, M.W.; Reynolds, E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry 2000, 69, 228–232, doi:10.1136/jnnp.69.2.228.
[31]  Papakostas, G.I. Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder. J. Clin. Psychiatry 2009, 70, 18–22, doi:10.4088/JCP.8157su1c.04.
[32]  Tiemeier, H.; van Tuijl, H.R.; Hofman, A.; Meijer, J.; Kiliaan, A.J.; Breteler, M.M. Vitamin B12, folate, and homocysteine in depression: The rotterdam study. Am. J. Psychiatry 2002, 159, 2099–2101, doi:10.1176/appi.ajp.159.12.2099.
[33]  Penninx, B.W.; Guralnik, J.M.; Ferrucci, L.; Fried, L.P.; Allen, R.H.; Stabler, S.P. Vitamin B(12) deficiency and depression in physically disabled older women: Epidemiologic evidence from the women’s health and aging study. Am. J. Psychiatry 2000, 157, 715–721, doi:10.1176/appi.ajp.157.5.715.
[34]  Hintikka, J.; Tolmunen, T.; Tanskanen, A.; Viinamaki, H. High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry 2003, 3, 17.
[35]  Hector, M.; Burton, J.R. What are the psychiatric manifestations of vitamin B12 deficiency? J. Am. Geriatr. Soc. 1988, 36, 1105–1112.
[36]  Buchman, N.; Mendelsson, E.; Lerner, V.; Kotler, M. Delirium associated with vitamin B12 deficiency after pneumonia. Clin. Neuropharmacol. 1999, 22, 356–358.
[37]  Lerner, V.; Kanevsky, M. Acute dementia with delirium due to vitamin B12 deficiency: A case report. Int. J. Psychiatry Med. 2002, 32, 215–220, doi:10.2190/C2MU-AHVC-3092-X2TB.
[38]  Goebels, N.; Soyka, M. Dementia associated with vitamin B(12) deficiency: Presentation of two cases and review of the literature. J. Neuropsychiatry Clin. Neurosci. 2000, 12, 389–394, doi:10.1176/appi.neuropsych.12.3.389.
[39]  Van Goor, L.; Woiski, M.D.; Lagaay, A.M.; Meinders, A.E.; Tak, P.P. Review: Cobalamin deficiency and mental impairment in elderly people. Age Ageing 1995, 24, 536–542, doi:10.1093/ageing/24.6.536.
[40]  Morris, M.C.; Schneider, J.A.; Tangney, C.C. Thoughts on B-vitamins and dementia. J. Alzheimer's Dis. 2006, 9, 429–433.
[41]  Stabler, S.P.; Allen, R.H.; Savage, D.G.; Lindenbaum, J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990, 76, 871–881.
[42]  Whyte, E.M.; Mulsant, B.H.; Butters, M.A.; Qayyum, M.; Towers, A.; Sweet, R.A.; Klunk, W.; Wisniewski, S.; DeKosky, S.T. Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia. Am. J. Geriatr. Psychiatry 2002, 10, 321–327.
[43]  Chiu, H.F.K. Vitamin B12 deficiency and dementia. Int. J. Geriatr. Psychiatry 1996, 11, 851–858, doi:10.1002/(SICI)1099-1166(199610)11:10<851::AID-GPS452>3.0.CO;2-L.
[44]  Blundo, C.; Marin, D.; Ricci, M. Vitamin B12 deficiency associated with symptoms of frontotemporal dementia. Neurol. Sci. 2011, 32, 101–105, doi:10.1007/s10072-010-0419-x.
[45]  Schreinzer, D.; Barnas, C.; Fischer, P. Frontotemporal dementia associated with vitamin B12 deficiency. J. Am. Geriatr. Soc. 2003, 51, 280–281, doi:10.1046/j.1532-5415.2003.51075.x.
[46]  Akdal, G.; Yener, G.G.; Kurt, P. Treatment responsive executive and behavioral dysfunction associated with vitamin B12 deficiency. Neurocase 2008, 14, 147–150, doi:10.1080/13554790802032242.
[47]  Osimani, A.; Berger, A.; Friedman, J.; Porat-Katz, B.S.; Abarbanel, J.M. Neuropsychology of vitamin B12 deficiency in elderly dementia patients and control subjects. J. Geriatr. Psychiatry Neurol. 2005, 18, 33–38, doi:10.1177/0891988704272308.
[48]  Eastley, R.; Wilcock, G.K.; Bucks, R.S. Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function. Int. J. Geriatr. Psychiatry 2000, 15, 226–233, doi:10.1002/(SICI)1099-1166(200003)15:3<226::AID-GPS98>3.0.CO;2-K.
[49]  Malouf, R.; Areosa Sastre, A. Vitamin B12 for cognition. Cochrane Database Syst. Rev. 2003, doi:10.1002/14651858.CD004326.
[50]  Douaud, G.; Refsum, H.; de Jager, C.A.; Jacoby, R.; Nichols, T.E.; Smith, S.M.; Smith, A.D. Preventing alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. USA 2013, 110, 9523–9528.
[51]  Yamada, K.; Shrier, D.A.; Tanaka, H.; Numaguchi, Y. A case of subacute combined degeneration: MRI findings. Neuroradiology 1998, 40, 398–400, doi:10.1007/s002340050610.
[52]  Okada, S.; Kuwako, T.; Nakajo, H.; Ishihara, M.; Uchiyama, F.; Obo, R.; Yokose, N.; Hamamoto, M. Two cases of subacute combined degeneration: Magnetic resonance findings. J. Nippon Med. Sch. 2006, 73, 328–331, doi:10.1272/jnms.73.328.
[53]  Timms, S.R.; Cure, J.K.; Kurent, J.E. Subacute combined degeneration of the spinal cord: MR findings. AJNR 1993, 14, 1224–1227.
[54]  Tajima, Y.; Mito, Y.; Owada, Y.; Moriwaka, F.; Tashiro, K. MR appearance of subacute combined degeneration of the spinal cord. Jpn. J. Psychiatry Neurol. 1994, 48, 611–614.
[55]  Katsaros, V.K.; Glocker, F.X.; Hemmer, B.; Schumacher, M. MRI of spinal cord and brain lesions in subacute combined degeneration. Neuroradiology 1998, 40, 716–719, doi:10.1007/s002340050670.
[56]  Berlit, P.; Ringelstein, A.; Liebig, T. Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency. Neurology 2004, 63, 592.
[57]  Ravina, B.; Loevner, L.A.; Bank, W. MR findings in subacute combined degeneration of the spinal cord: A case of reversible cervical myelopathy. Am. J. Roentgenol. 2000, 174, 863–865, doi:10.2214/ajr.174.3.1740863.
[58]  Nakamura, K.; Mukherjee, P.; Swanson, R.A. Vitamin B12 deficiency. Arch. Neurol. 2004, 61, 960, doi:10.1001/archneur.61.6.960.
[59]  Karantanas, A.H.; Markonis, A.; Bisbiyiannis, G. Subacute combined degeneration of the spinal cord with involvement of the anterior columns: A new MRI finding. Neuroradiology 2000, 42, 115–117.
[60]  Tian, C. Hyperintense signal on spinal cord diffusion-weighted imaging in a patient with subacute combined degeneration. Neurol. India 2011, 59, 429–431, doi:10.4103/0028-3886.82764.
[61]  Scalabrino, G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: Traditional interpretations and novel theories. Exp. Neurol. 2005, 192, 463–479, doi:10.1016/j.expneurol.2004.12.020.
[62]  Spinazzi, M.; de Lazzari, F.; Tavolato, B.; Angelini, C.; Manara, R.; Armani, M. Myelo-optico-neuropathy in copper deficiency occurring after partial gastrectomy. Do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance? J. Neurol. 2007, 254, 1012–1017.
[63]  Lovblad, K.; Ramelli, G.; Remonda, L.; Nirkko, A.C.; Ozdoba, C.; Schroth, G. Retardation of myelination due to dietary vitamin B12 deficiency: Cranial MRI findings. Pediatr. Radiol. 1997, 27, 155–158, doi:10.1007/s002470050090.
[64]  Kori, S. Hyperintense splenium in vitamin B12 deficiency. Neurol. India 2005, 53, 377–378, doi:10.4103/0028-3886.16959.
[65]  Cech, I.; Burau, K.D. Serological differences in folate/vitamin B12 in pregnancies affected by neural tube defects. South. Med. J. 2010, 103, 419–424, doi:10.1097/SMJ.0b013e3181d90be2.
[66]  Wenz, H.; Eisele, P.; Artemis, D.; Forster, A.; Brockmann, M.A. Acute marchiafava-bignami disease with extensive diffusion restriction and early recovery: Case report and review of the literature. J. Neuroimaging 2012, doi:10.1111/j.1552-6569.2012.00755.x.
[67]  Misra, U.K.; Kalita, J.; Das, A. Vitamin B12 deficiency neurological syndromes: A clinical, MRI and electrodiagnostic study. Electromyogr. Clin. Neurophysiol. 2003, 43, 57–64.
[68]  De Lau, L.M.; Smith, A.D.; Refsum, H.; Johnston, C.; Breteler, M.M. Plasma vitamin B12 status and cerebral white-matter lesions. J. Neurol. Neurosurg. Psychiatry 2009, 80, 149–157.
[69]  Scott, T.M.; Tucker, K.L.; Bhadelia, A.; Benjamin, B.; Patz, S.; Bhadelia, R.; Liebson, E.; Price, L.L.; Griffith, J.; Rosenberg, I.; et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am. J. Geriatr. Psychiatry 2004, 12, 631–638.
[70]  Graber, J.J.; Sherman, F.T.; Kaufmann, H.; Kolodny, E.H.; Sathe, S. Vitamin B12-responsive severe leukoencephalopathy and autonomic dysfunction in a patient with “normal” serum B12 levels. J. Neurol. Neurosurg. Psychiatry 2010, 81, 1369–1371, doi:10.1136/jnnp.2009.178657.
[71]  Lindenbaum, J.; Healton, E.B.; Savage, D.G.; Brust, J.C.; Garrett, T.J.; Podell, E.R.; Marcell, P.D.; Stabler, S.P.; Allen, R.H. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 1988, 318, 1720–1728, doi:10.1056/NEJM198806303182604.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133